HeartSciences (HSCS) Shares Outstanding (Weighted Average) (2021 - 2026)
HeartSciences posted quarterly Shares Outstanding (Weighted Average) of $2.1 million for Q1 2026, up 135.18% year-on-year from $894046.0 in Q1 2025, and little changed on a QoQ basis from $2.1 million in Q4 2025.
HeartSciences (HSCS) has 6 years of Shares Outstanding (Weighted Average) data on file, last reported at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 135.18% year-over-year to $2.1 million; the trailing twelve-month figure through Jan 2026 stood at $2.1 million (up 135.18% YoY), and the FY2025 full-year result was $121055.0, down 65.66% from the prior year.
- Shares Outstanding (Weighted Average) for Q1 2026 stood at $2.1 million, roughly flat from $2.1 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $8.2 million in Q1 2023 and bottomed at $79506.0 in Q2 2023.
- The 5-year median for Shares Outstanding (Weighted Average) is $917445.0 (2024), against an average of $2.2 million.
- The widest annual swing landed in 2023, when Shares Outstanding (Weighted Average) plunged 98.46%; it then surged 760.79% in 2024.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $6.9 million in 2022, then slumped by 98.46% to $106582.0 in 2023, then soared by 760.79% to $917445.0 in 2024, then surged by 128.57% to $2.1 million in 2025, then rose by 0.27% to $2.1 million in 2026.
- The last three Shares Outstanding (Weighted Average) figures came in at $2.1 million (Q1 2026), $2.1 million (Q4 2025), and $1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.28 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 385.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 98.20 Mn |
| 10 | HeartSciences | 4.56 Mn | 1.16 Mn | - | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 2.10 Mn |
| Oct 31, 2025 | 2.10 Mn |
| Jul 31, 2025 | 1.30 Mn |
| Apr 30, 2025 | 121,055.00 |
| Jan 31, 2025 | 894,046.00 |
| Oct 31, 2024 | 917,445.00 |
| Jul 31, 2024 | 777,746.00 |
| Apr 30, 2024 | 352,520.00 |
| Jan 31, 2024 | 546,670.00 |
| Oct 31, 2023 | 106,582.00 |
| Jul 31, 2023 | 103,315.00 |
| Apr 30, 2023 | 79,506.00 |
| Jan 31, 2023 | 8.24 Mn |
| Oct 31, 2022 | 6.93 Mn |
| Jul 31, 2022 | 5.65 Mn |
| Apr 30, 2022 | 3.32 Mn |
| Jan 31, 2022 | 3.32 Mn |
| Oct 31, 2021 | 3.31 Mn |
| Jul 31, 2021 | 3.31 Mn |